Stem cell therapy for retinal ganglion cell degeneration
Ling-Ping Cen
Tsz Kin Ng
摘要：The prospects of stem cell therapy for retinal ganglion cell (RGC) degeneration in human:RGC degeneration is a common pathologic cause of glaucoma and optic neuropathies,which are the leading cause of irreversible blindness and visual impairment in developed countries,currently affecting more than 100 million people worldwide.Intraocular pressure lowering can slow down glaucoma progression in a proportion of patients.
机标关键词：
资助基金：This work was supported in part by the National Natural Science Foundation of China(81570849 and 81470636)Research Fund for the Doctoral Program of Higher Education of China(20114402120007)Natural Science Foundation of Guangdong Province(2015A030313446)
论文发表日期：2018-01-01
在线出版日期：2025-08-15（本平台首次上网日期，不代表文献的发表时间）
页数：2( 1352-1353 )